Clinical trial · Observational
Knowledge, Attitude &Practice on Human Papilloma Virus Vaccination Among Healthcare Providers and General Population
Knowledge,Attitude &Practice on Human Papilloma Virus Vaccination Among Healthcare Providers and General Population
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
* Cervical cancer is caused by persistent infection with certain strains of the human papillomavirus (HPV), which is a very common virus transmitted through sexual activity. * HPV infections can lead to the development of precancerous lesions on the cervix, which if left untreated, can progress to invasive cervical cancer over time. * Cervical cancer is the second most common cancer among women in Egypt, after breast cancer. * According to the latest available data, the age-standardized incidence rate of cervical cancer in Egypt is approximately 6.3 per 100,000 women. * However, the actual burden of cervical cancer in Egypt is likely underestimated, as many cases may go undetected or unreported, especially in rural and underserved areas. The main objectives of this KAP study are: 1. To assess the level of knowledge about HPV and HPV vaccination among the target population. 2. To investigate the attitudes and perceptions towards HPV vaccination. 3. To identify the current practices and uptake of HPV vaccination. 4. To explore the factors influencing the knowledge, attitudes, and practices related to HPV vaccination.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Human Papilloma Virus (HPV) Vaccine | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- health care provider group
- description
- \- Healthcare providers at the Gynecologic Oncology Unit have direct interactions with patients and can significantly influence their knowledge, attitudes, and decision-making regarding HPV vaccination.
Primary outcomes (2)
- measure
- Knowledge about HPV
- timeFrame
- baseline
- description
- Proportion of participants with adequate knowledge about HPV
- measure
- Knowledge about HPV Vaccination
- timeFrame
- baseline
- description
- Proportion of participants with adequate knowledge about the HPV vaccine
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 9 Years
- Maximum age
- 79 Years
Show eligibility criteria text
Inclusion Criteria: * 1\. general population: * Eligibility criteria: * Age: 9-79 years old * patients and their relatives * Attending the Obstetrics and Gynecology, or Family Medicine clinics at Assiut University Hospital * Recruitment strategy: * Using a systematic random sampling method, every nth patient (based on the average patient load) will be approached and invited to participate in the study. * The target sample size for patients is a minimum of 384 participants. 2\. Healthcare providers: * Eligibility criteria: * Physicians, nurses, and other healthcare workers employed in the Obstetrics and Gynecology, and Family Medicine departments at Assiut University Hospital. Exclusion Criteria: * -Previous HPV Vaccination: * Exclude participants who have already received the complete HPV vaccination series, as their knowledge, attitudes, and practices may differ from those who are unvaccinated. * The study aims to understand the KAP of the unvaccinated population, which is the primary target group for intervention. 2-Severe Cognitive or Mental Impairment: * Exclude participants who have severe cognitive or mental impairments that may prevent them from understanding and responding to the questionnaire accurately. * This could include individuals with advanced dementia, severe intellectual disabilities, or acute psychiatric conditions. 3-. Inability to Provide Informed Consent: * Exclude participants who are unable to provide informed consent due to language barriers, literacy issues, or other factors that may compromise their ability to understand the study and its implications 4- Severe Illness or Hospitalization: * Exclude participants who are currently hospitalized or experiencing severe illness, as their focus may be on their immediate health concerns rather than the KAP questionnaire.
References
Publications (1)
- RESULTBrewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007 Aug-Sep;45(2-3):107-14. doi: 10.1016/j.ypmed.2007.05.013. Epub 2007 Jun 2. PMID 17628649